weight regain after tirzepatide the withdrawal of (Zepbound) may wipe out many of the cardiometabolic gains made during weight loss, a post-hoc analysis of the SURMOUNT-4 trial indicated. Read more at: https://www.medpagetoday.com/endocrinology/obesity People who stop weight loss
Description
Based on SURMOUNT-1 data, participants on the 15 mg dose were averaging roughly 15% body weight loss by around this point in the trial
Phase 3 trials are underway with potential approval in 2027
Transition safety protocol From 10mg/ml to 20mg/ml: Cut your unit draw in half
(the platform): Manages the online intake, account management, payment processing, and coordination between providers and pharmacies
Headaches are classified as 'common' side effects in the Summary of Product Characteristics for semaglutide (Wegovy) and liraglutide (Saxenda)
